BIIB059, a monoclonal antibody targeting BDCA2, decreases Type I Interferon-related genes transcriptional activity in subjects with systemic lupus erythematosus (SLE) and active cutaneous LE (CLE)-MedSci.cn

BIIB059, a monoclonal antibody targeting BDCA2, decreases Type I Interferon-related genes transcriptional activity in subjects with systemic lupus erythematosus (SLE) and active cutaneous LE (CLE)

Werth, VP; Merola, JF; Furie, R; Reynolds, TL; Stevenson, L; Wang, W; Musselli, C; Christmann, R; Hamann, S; Zhang, X; Barbey, C; Rabah, D; Franchimont, N

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018; 138 (5): S183

科室
- - 订阅+
  - 更多科室
工具
服务